Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
BioSig Technologies, Inc. recently rebranded as Streamex Corp., effective September 12, 2025, following its merger with Streamex Exchange Corporation. The company shifted focus from healthcare technology to real-world asset tokenization, especially integrating the gold and commodities market into blockchain technology. Streamex provides institutional-grade infrastructure for tokenizing assets powered by a gold-denominated treasury.
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks.
Target Price
The average target price of BSGM is 10.0 and suggests 64% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell